DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Combivent (Ipratropium Bromide / Albuterol Sulfate) - News

 
 



News related to Combivent (Ipratropium / Albuterol) and/or conditions it is approved for

COPD (Chronic Obstructive Pulmonary Disease)
Source: MedicineNet Alpha 1 Antitrypsin Deficiency Specialty [2014.03.18]
Title: COPD (Chronic Obstructive Pulmonary Disease)
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 3/18/2014 7:18:35 PM

COPD Foods Pictures Slideshow: Energy-Boosting Foods for Chronic Obstructive Pulmonary Disease
Source: MedicineNet Chronic Obstructive Pulmonary Disease (COPD) Specialty [2013.11.20]
Title: COPD Foods Pictures Slideshow: Energy-Boosting Foods for Chronic Obstructive Pulmonary Disease
Category: Slideshows
Created: 6/18/2010 12:20:00 PM
Last Editorial Review: 11/20/2013 12:00:00 AM

COPD (Chronic Obstructive Pulmonary Disease) Quiz
Source: MedicineNet Chronic Obstructive Pulmonary Disease (COPD) Specialty [2012.11.06]
Title: COPD (Chronic Obstructive Pulmonary Disease) Quiz
Category: MedicineNet Quiz
Created: 10/8/2012 5:18:00 PM
Last Editorial Review: 11/6/2012 5:24:02 PM

A new once-daily dual bronchodilator treatment for COPD now available in England
Source: Respiratory / Asthma News From Medical News Today [2014.09.23]
GlaxoSmithKline and Theravance, Inc. announce that Anoro® Ellipta®, a new once-daily dual bronchodilator treatment for chronic obstructive pulmonary disease (COPD), is now available via GP...

Combination therapy for COPD associated with better outcomes
Source: Respiratory / Asthma News From Medical News Today [2014.09.16]
Among older adults with chronic obstructive pulmonary disease (COPD), particularly those with asthma, newly prescribed long-acting beta-agonists (LABAs) and inhaled corticosteroid combination...

New evidence points to outcomes and cost benefits of telemedicine in managing chronic diseases
Source: IT / Internet / E-mail News From Medical News Today [2014.09.12]
Congestive heart failure, stroke, and chronic obstructive pulmonary disease (COPD) are three of the leading causes of death in the U.S.

COPD: Is Stepping Down Therapy Safe?
Source: MedPage Today Allergy & Immunology [2014.09.09]
(MedPage Today) -- Cutting glucocorticoids from maximal inhaled therapy for moderate-to-severe chronic obstructive pulmonary disease didn't worsen control over exacerbations, a trial showed.

Biologic Yields Mixed Results in COPD
Source: MedPage Today Allergy & Immunology [2014.09.08]
(MedPage Today) -- The eosinophil-depleting monoclonal antibody benralizumab didn't cut acute exacerbations in eosinophilic chronic obstructive pulmonary disease in an early phase study.

FDA Panel Greenlights COPD Mist Drug
Source: MedPage Today Allergy & Immunology [2014.08.14]
(MedPage Today) -- A mist formulation of a drug aimed at chronic obstructive pulmonary disease (COPD) should be approved, an FDA panel agreed, with concerns about its safety described as "niggling."

Safety on Table as FDA Panel Mulls COPD Drug
Source: MedPage Today Allergy & Immunology [2014.08.13]
(MedPage Today) -- Safety will be the main issue when an FDA advisory panel considers the mist version of a drug aimed at chronic obstructive pulmonary disease (COPD).

FDA Approves Long-Acting COPD Inhaler
Source: MedPage Today Allergy & Immunology [2014.08.01]
(MedPage Today) -- The FDA approved another once-daily bronchodilator, olodaterol (Striverdi Respimat), for maintenance treatment of chronic obstructive pulmonary disease (COPD).

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014